文献速递运动医学关节外科

ACL重建合并半月板损伤时膝关节滑液生物标志物类型与浓度及长期结局

Knee Synovial Fluid Biomarker Type and Concentration With Long-Term Outcomes After ACL Reconstruction With Concomitant Meniscal Injury.
PubMed 文献 · Am J Sports Med · 2026-06-29

本研究前瞻性纳入97例关节镜下ACL重建合并半月板损伤患者,术前检测滑液10种生物标志物,用k-means聚类分为高炎症(n=66)和低炎症(n=31)表型。高炎症组基线疼痛和功能更差,但平均8.2年随访时术后PROMs相似,且高炎症组VAS疼痛和Lysholm评分改善更大;MCP-1与PROMs的关联呈表型依赖。

要点

  • ACL重建合并半月板损伤患者滑液存在高、低炎症两种表型。
  • 高炎症表型基线疼痛和功能更差,但长期PROMs与低炎症组相似。
  • 高炎症组VAS疼痛和Lysholm评分改善幅度更大,MCP-1关联呈表型依赖。

核心结论

  • ACL重建合并半月板损伤时滑液生物标志物谱可识别与基线症状严重度和临床改善模式相关的不同炎症表型。
  • 尽管长期PROMs组间相似,但表型依赖的生物标志物关联(尤其MCP-1)提示恢复的生物学背景因炎症谱而异。

研究设计与样本

  • 队列研究,证据等级3级。
  • 2011年7月至2024年1月前瞻性纳入接受关节镜下ACL重建合并半月板损伤的患者,术前切皮前抽取滑液并量化10种生物标志物浓度。
  • 采用无监督k-means聚类识别高炎症和低炎症表型,线性回归评估生物标志物与PROMs的关联,交互模型评估炎症表型的效应修饰。
  • MCID达成阈值采用分布法(0.5×基线SD)计算并在聚类间比较。

主要发现

  • 共97例患者分为高炎症组(n=66)和低炎症组(n=31),患者和手术特征相似。
  • 高炎症组基线疼痛和功能显著更差(所有P≤.008)。
  • 平均随访8.2±2.5年时,术后PROMs相似,但高炎症组VAS疼痛改善更大(-13.5 vs 3.1;P=.008),Lysholm改善更大(28.6 vs 8.9;P=.002)。
  • MCP-1与PROMs呈强表型依赖关联,高炎症患者更可能达到VAS疼痛的MCID(57.6% vs 17.6%;P<.05)。

关键数值与推荐

  • 高炎症组VAS疼痛改善-13.5,低炎症组3.1(P=.008)。
  • 高炎症组Lysholm改善28.6,低炎症组8.9(P=.002)。
  • 高炎症组VAS疼痛MCID达成率57.6%,低炎症组17.6%(P<.05)。
  • 高炎症组基线疼痛和功能更差,所有P≤.008。

临床怎么用

  • ACL重建合并半月板损伤时可考虑术前滑液生物标志物检测以识别炎症表型。
  • 高炎症表型患者基线症状更重但长期PROMs与低炎症组相似,且疼痛和功能改善幅度更大。
  • MCP-1等表型依赖生物标志物可能有助于理解恢复的生物学背景,但尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anterior cruciate ligament (ACL) rupture frequently occurs alongside meniscal injury, together altering the intra-articular environment. While ACL injury triggers an inflammatory cascade within synovial fluid, meniscal injury may intensify these responses, contributing to joint degeneration. However, little is known about how combined ACL and meniscal injuries shape the synovial inflammatory milieu or whether these profiles influence long-term outcomes. PURPOSE/HYPOTHESIS: The purpose was to characterize synovial fluid inflammatory phenotypes at the time of ACL reconstruction with concomitant meniscal injury and assess their association with patient-reported outcome measures (PROMs) and clinically meaningful improvement. It was hypothesized that (1) distinct inflammatory phenotypes would exist, (2) these phenotypes would correlate with symptom severity and recovery, and (3) individual biomarkers' effects on outcomes would vary by phenotype. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Patients undergoing arthroscopic ACL reconstruction with concomitant meniscal injury were prospectively enrolled between July 2011 and January 2024. Synovial fluid was aspirated before incision, and the concentrations of 10 biomarkers were quantified. Unsupervised k-means clustering identified high- and low-inflammation phenotypes. PROMs were collected preoperatively on the day of surgery (baseline) and at long-term follow-up. Linear regression assessed biomarker associations with PROMs, with interaction models evaluating effect modification by inflammation phenotype. Minimal clinically important difference (MCID) achievement thresholds were calculated using a distribution-based approach (0.5 × baseline SD) and compared between clusters. RESULTS: A total of 97 patients were stratified into high-inflammation (n = 66) and low-inflammation (n = 31) clusters. Patient and surgical characteristics were similar, but the high-inflammation cluster demonstrated significantly worse baseline pain and function (all P≤ .008). At a mean follow-up of 8.2 ± 2.5 years, postoperative PROMs were similar, but the high-inflammation cluster experienced greater improvements in VAS pain (-13.5 vs 3.1; P = .008) and Lysholm (28.6 vs 8.9; P = .002) scores. Monocyte chemoattractant protein-1 (MCP-1) demonstrated strong, phenotype-dependent associations with PROMs, and patients with high inflammation were more likely to achieve the MCID for VAS pain score (57.6% vs 17.6%; P < .05). CONCLUSION: Synovial fluid biomarker profiles at the time of ACL reconstruction with concomitant meniscal injury identified distinct inflammatory phenotypes associated with baseline symptom severity and differential patterns of clinical improvement. Although long-term PROMs were similar between groups, phenotype-dependent biomarker associations, particularly involving MCP-1, suggest that the biological context of recovery differs across inflammatory profiles.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Ehlers M, Estes LC, Derry K, et al. Knee Synovial Fluid Biomarker Type and Concentration With Long-Term Outcomes After ACL Reconstruction With Concomitant Meniscal Injury. Am J Sports Med. 2026. PMID: 42367029. doi:10.1177/03635465261459225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。